Boston Scientific’s Penumbra Acquisition: Impacts and 3D Printing Opportunities in Vascular Medicine
Anthony Palumbo and Charles Goulding analyze Boston Scientific’s US$14.5 billion acquisition of Penumbra, showing how additive manufacturing can accelerate thrombectomy and neurovascular innovation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results